Case Study: Home-Based Pain Plans in Cancer Trials Cut Opioids
Home-based pain plans validated in 2024–2025 trials cut opioid exposure by ~30% while preserving pain control. Success depends on caregiver education, simple algorithms, early telehealth follow-up, and seasonal preparedness for flu.
Robert Maxwell
Sep 17, 2025
neuropathic pain trials
palliative chemotherapy support
non-opioid analgesics
caregiver pain protocols
